Jagsonpal Pharmaceuticals Ltd
NSE: JAGSNPHARM BSE: 507789
₹168.67
(0.01%)
Wed, 04 Mar 2026, 05:46 am
Market Cap11.3B
PE Ratio27.54
Dividend1.48
Jagsonpal Pharmaceuticals Income Statement
| Particulars | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 1.56B | 1.29B | 1.50B | 1.36B | 1.40B | 1.61B | 1.77B | 1.66B | 1.44B | 1.38B | 1.43B | 1.44B | 1.27B | 1.67B | 1.59B | 1.88B | 2.18B | 2.37B | 2.09B | 2.69B |
| Gross profit | 367.96M | 309.21M | 362.93M | 354.81M | 356.83M | 405.04M | 493.64M | 357.80M | 346.83M | 318.65M | 399.49M | 394.24M | 212.71M | 442.12M | 500.47M | 513.81M | 686.32M | 767.99M | 649.30M | 927.91M |
| Operating expenses (excl. COGS) | -247.90M | -216.96M | -253.73M | -216.38M | -220.49M | -281.75M | -352.71M | -284.26M | -268.31M | -258.46M | -312.33M | -353.07M | -326.81M | -358.87M | -425.63M | -333.65M | -440.15M | -425.92M | -429.06M | -492.42M |
| Selling/general/admin expenses, total | -241.59M | -214.08M | -250.05M | -212.74M | -220.49M | -281.75M | -352.01M | -283.47M | -265.81M | -257.54M | -312.02M | -351.28M | -323.83M | -348.90M | -414.82M | -318.99M | -436.54M | -422.42M | -424.15M | -484.65M |
| Research & development | -7.25M | -6.16M | -6.03M | -3.67M | -4.65M | -5.41M | -7.62M | -6.93M | — | — | -4.69M | -5.64M | -3.74M | — | — | — | 0 | — | 0 | 0 |
| Selling/general/admin expenses, other | -234.34M | -207.92M | -244.02M | -209.07M | -215.85M | -276.33M | -344.39M | -276.54M | -265.81M | -257.54M | -307.34M | -345.63M | -320.08M | -348.90M | -414.82M | -318.99M | -436.54M | -422.42M | -424.15M | -484.65M |
| Other operating expenses, total | -6.31M | -2.88M | -3.68M | -3.64M | 0 | 0 | -694.00K | -786.00K | -2.50M | -920.00K | -306.00K | -1.79M | -2.98M | -9.97M | -10.82M | -14.66M | -3.61M | -3.50M | -4.91M | -7.77M |
| Operating income | 120.06M | 92.25M | 109.20M | 138.44M | 136.33M | 123.30M | 140.94M | 73.55M | 78.53M | 60.19M | 87.16M | 41.17M | -114.09M | 83.25M | 74.84M | 180.16M | 246.17M | 342.07M | 220.24M | 435.49M |
| Non-operating income, total | -42.10M | -48.57M | -60.96M | -43.09M | -31.33M | -30.62M | -40.04M | -48.18M | -53.21M | -43.48M | -46.41M | 102.80M | -2.17M | 6.77M | 19.31M | 38.56M | 20.25M | 6.01M | 78.45M | 263.10M |
| Interest expense, net of interest capitalized | -46.99M | -56.30M | -63.51M | -45.79M | -34.96M | -33.22M | -43.58M | -51.34M | -53.82M | -44.59M | -52.97M | -26.45M | -1.57M | -7.46M | -5.14M | -5.13M | -2.85M | -4.13M | -8.14M | -9.58M |
| Interest capitalized | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-operating income, excl. interest expenses | 4.88M | 7.73M | 2.55M | 2.71M | 3.63M | 2.60M | 3.54M | 3.15M | 607.00K | 1.11M | 6.56M | 129.24M | -602.00K | 14.23M | 24.45M | 33.25M | 28.26M | 49.47M | 86.59M | 309.40M |
| Non-operating interest income | 0 | 0 | 0 | 0 | — | — | 475.00K | 319.00K | 592.00K | 131.00K | 634.00K | 1.26M | 3.36M | 12.97M | 21.68M | 29.92M | 15.46M | 33.94M | 85.92M | 76.45M |
| Miscellaneous non-operating expense | 4.88M | 7.73M | 2.55M | 2.71M | 3.63M | 2.60M | 3.07M | 2.83M | 15.00K | 980.00K | 5.93M | 127.98M | -3.96M | 1.26M | 2.77M | 3.33M | 12.80M | 15.53M | 670.00K | 232.95M |
| Unusual income/expense | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 0 | 10.44M | -5.16M | -39.33M | 0 | -36.72M |
| Pretax income | 77.95M | 43.67M | 48.24M | 95.35M | 105.00M | 92.68M | 100.90M | 25.36M | 25.31M | 16.72M | 40.75M | 143.97M | -116.27M | 90.03M | 94.15M | 218.72M | 266.42M | 348.08M | 298.69M | 698.59M |
| Taxes | -51.70M | -15.64M | -17.48M | -33.63M | -12.58M | -20.88M | -26.33M | -7.04M | -4.11M | -5.01M | -8.21M | -25.32M | 761.00K | -17.87M | -15.44M | -48.14M | -77.87M | -80.87M | -74.06M | -144.98M |
| Non-controlling/minority interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| After tax other income/expense | 0 | 0 | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income before discontinued operations | 26.25M | 28.03M | 30.76M | 61.72M | 92.42M | 71.80M | 74.57M | 18.33M | 21.21M | 11.71M | 32.54M | 118.65M | -115.51M | 72.16M | 78.71M | 170.58M | 188.55M | 267.21M | 224.63M | 553.61M |
| Net income | 26.25M | 28.03M | 30.76M | 61.72M | 92.42M | 71.80M | 74.57M | 18.33M | 21.21M | 11.71M | 32.54M | 118.65M | -115.51M | 72.16M | 78.71M | 170.58M | 188.55M | 267.21M | 224.63M | 553.61M |
| Dilution adjustment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted net income available to common stockholders | 26.25M | 28.03M | 30.76M | 61.72M | 92.42M | 71.80M | 74.57M | 18.33M | 21.21M | 11.71M | 32.54M | 118.65M | -115.51M | 72.16M | 78.71M | 170.58M | 188.55M | 267.21M | 224.63M | 553.61M |
| Basic earnings per share (Basic EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Diluted earnings per share (Diluted EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA | 135.15M | 108.77M | 126.07M | 150.93M | 157.18M | 145.31M | 166.30M | 100.62M | 106.78M | 87.26M | 118.10M | 61.11M | -110.90M | 93.41M | 86.14M | 191.02M | 261.43M | 353.82M | 236.87M | 516.80M |
| EBIT | 120.06M | 92.25M | 109.20M | 138.44M | 136.33M | 123.30M | 140.94M | 73.55M | 78.53M | 60.19M | 87.16M | 41.17M | -114.09M | 83.25M | 74.84M | 180.16M | 246.17M | 342.07M | 220.24M | 435.49M |
| Total operating expenses | -1.44B | -1.20B | -1.39B | -1.22B | -1.26B | -1.49B | -1.62B | -1.59B | -1.36B | -1.32B | -1.35B | -1.40B | -1.38B | -1.59B | -1.51B | -1.70B | -1.93B | -2.03B | -1.87B | -2.25B |
| Prepaid expenses | 57.89M | 77.97M | 37.02M | — | — | 26.32M | — | — | — | — | — | — | — | — | — | — | 10.62M | 10.68M | 13.59M | 16.62M |
| Deferred income, current | — | — | — | — | — | — | 7.41M | — | — | — | — | — | — | — | — | — | — | 6.12M | 12.94M | 9.10M |
| Capital and operating lease obligations | — | — | — | — | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 52.47M | 52.47M | 75.57M | 76.32M |
| Operating lease liabilities | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Deferred tax liabilities | 25.81M | 25.26M | 23.93M | 25.62M | 30.96M | 33.68M | 39.83M | 41.79M | 40.84M | 36.03M | 36.09M | 32.61M | 31.85M | 31.85M | 30.92M | 2.52M | 41.02M | 22.04M | 43.23M | 53.95M |
| Deferred income, non-current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — | — | — | — | — | — | — | 6.66M |
| Minority interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in accrued expenses | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Common dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | -13.10M | -13.10M | -15.32M | -3.14M | -3.15M | -3.15M | -3.15M | -7.90M | -13.10M | -26.20M | -104.79M | 0 | -130.99M | -132.29M |
| Preferred dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Open Your Free Demat Account Now!
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800